Skip to main content

Table 5 Anti-HCV seroprevalence and HCV RNA in AIDS and non-Aids individuals

From: Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians

  AIDS
(N = 190)
Non-AIDS
(N = 382)
*ELISA positive 37 (19.4%) 26 (6.8%)
**RIBA positive 2/37 (5.4%) 5/26 (19.2%)
***RT-PCR positive 1/37 (2.7%) 3/26 (11.5%)
  1. * The ELISA positive individuals in the AIDS group include 24/142 (16.9%) HIV-1, 6/29 (20.1%) HIV- 2 and 7/19) (36.8%) HIV-Duals compared to 8/157 (5.0%) HIV-1, 18/215 (8.3%) HIV- 2 and none HIV-Duals in the non-AIDS group.
  2. ** HCV antibody test was confirmed in 1 AIDS and 3 non-AIDS patients in the HIV-2 group and in 1 AIDS and 2 non-AIDS in the HIV-1 group
  3. ***50% (1/1) and 60% (3/5) RIBA positive samples had detectable HCV-RNA.
  4. 5 samples (4 AIDS and 1 non-AIDS) had indeterminate result by ELISA but were negative for RT-PCR